ERN1 and glioblastoma: Furthermore, experiments performed in primary RADH87 and common U87 glioblastoma multiforme (GBM) cell lines have shown that all drugs influence IRE1 activity, with the IC50 values ranging between 0.2–2 μM, and thus they have similar potency to that of specific RNase inhibitor MKC-8866.